相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GSK3640254 Is a Novel HIV-1 Maturation Inhibitor with an Optimized Virology Profile
Ira Dicker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254
Christoph D. Spinner et al.
CLINICAL INFECTIOUS DISEASES (2022)
Update and latest advances in antiretroviral therapy
Luis Menendez-Arias et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy Participants
Mark Johnson et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2022)
Design and exploration of C-3 benzoic acid bioisosteres and alkyl replacements in the context of GSK3532795 (BMS-955176) that exhibit broad spectrum HIV-1 maturation inhibition
Jacob J. Swidorski et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Inositol phosphates promote HIV-1 assembly and maturation to facilitate viral spread in human CD4+ T cells
Gregory A. Sowd et al.
PLOS PATHOGENS (2021)
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
Murugaiah A. M. Subbaiah et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Preservation of HIV-1 Gag Helical Bundle Symmetry by Bevirimat Is Central to Maturation Inhibition
Alexander J. Pak et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Phase I evaluation of pharmacokinetics and tolerability of the HIV-1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults
Teodora Pene Dumitrescu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
The HIV-1 capsid and reverse transcription
Christopher Aiken et al.
RETROVIROLOGY (2021)
A stable immature lattice packages IP6 for HIV capsid maturation
Donna L. Mallery et al.
SCIENCE ADVANCES (2021)
A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants
Teodora Pene Dumitrescu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
CryoET structures of immature HIV Gag reveal six-helix bundle
Luiza Mendonca et al.
COMMUNICATIONS BIOLOGY (2021)
Diethylaminosulfur Trifluoride (DAST) Mediated Transformations Leading to Valuable Building Blocks and Bioactive Compounds
Marcin Kazmierczak et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2021)
A Structural Perspective of the Role of IP6 in Immature and Mature Retroviral Assembly
Martin Obr et al.
VIRUSES-BASEL (2021)
Uridine diphosphate glucuronosyltransferase 1A1
Glyn Steventon
XENOBIOTICA (2020)
Combination therapies currently under investigation in phase I and phase II clinical trials for HIV-1
Hanh Thi Pham et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles
Sebanti Gupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Recent Advances in the Protection of Amine Functionality: A Review
Jyoti Omprakash Rathi et al.
CHEMISTRYSELECT (2020)
Impact of Cross-Coupling Reactions in Drug Discovery and Development
Melissa J. Buskes et al.
MOLECULES (2020)
Primate lentiviruses require Inositol hexakisphosphate (IP6) or inositol pentakisphosphate (IP5) for the production of viral particles
Clifton L. Ricana et al.
PLOS PATHOGENS (2020)
HIV-1 Maturation: Lessons Learned from Inhibitors
Alex B. Kleinpeter et al.
VIRUSES-BASEL (2020)
Atomic-scale characterization of mature HIV-1 capsid stabilization by inositol hexakisphosphate (IP6)
Alvin Yu et al.
SCIENCE ADVANCES (2020)
Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor
Samit R. Joshi et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
Assessment of Pharmacokinetic Drug-Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited
Uwe Fuhr et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Second Generation Inhibitors of HIV-1 Maturation
Alicia Regueiro-Ren et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle
Mariia Novikova et al.
VIROLOGICA SINICA (2019)
Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study
Ira Dicker et al.
PLOS ONE (2019)
The design, synthesis and structure-activity relationships associated with C28 amine-based betulinic acid derivatives as inhibitors of HIV-1 maturation
Yan Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Next generation fixed dose combination pharmacotherapies for treating HIV
Margaret R. Caplan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2018)
IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis
Donna L. Mallery et al.
ELIFE (2018)
The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry
Arun K. Ghosh et al.
CHEMMEDCHEM (2018)
Design, Synthesis, and SAR of C-3 Benzoic Acid, C-17 Triterpenoid Derivatives. Identification of the HIV-1 Maturation Inhibitor 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-((2-(1,1-Dioxidothiomorpholino)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)benzoic Acid (GSK3532795, BMS-955176)
Alicia Regueiro-Ren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Inositol phosphates are assembly co-factors for HIV-1
Robert A. Dick et al.
NATURE (2018)
Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial
Javier Morales-Ramirez et al.
PLOS ONE (2018)
The Human Immunodeficiency Virus Capsid Is More Than Just a Genome Package
Leo C. James et al.
ANNUAL REVIEW OF VIROLOGY, VOL 5 (2018)
MicroED structures of HIV-1 Gag CTD-SP1 reveal binding interactions with the maturation inhibitor bevirimat
Michael D. Purdy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
IP6 Regulation of HIV Capsid Assembly, Stability, and Uncoating
Robert A. Dick et al.
VIRUSES-BASEL (2018)
Drug-Target Kinetics in Drug Discovery
Peter J. Tonge
ACS CHEMICAL NEUROSCIENCE (2018)
The Second-Generation Maturation Inhibitor GSK3532795 Maintains Potent Activity Toward HIV Protease Inhibitor-Resistant Clinical Isolates
Neelanjana Ray et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Antiviral Activity, Safety, and Exposure-Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002)
Carey Hwang et al.
CLINICAL INFECTIOUS DISEASES (2017)
Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage
Beata Nowicka-Sans et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
HIV Capsid Assembly, Mechanism, and Structure
Bo Chen
BIOCHEMISTRY (2016)
C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors
Zheng Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Inhibitors of HIV-1 maturation: Development of structure-activity relationship for C-28 amides based on C-3 benzoic acid-modified triterpenoids
Jacob J. Swidorski et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation
Florian K. M. Schur et al.
SCIENCE (2016)
Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity
Alicia Regueiro-Ren et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors
Zeyu Lin et al.
PLOS PATHOGENS (2016)
Crystal structure of an HIV assembly and maturation switch
Jonathan M. Wagner et al.
ELIFE (2016)
Applications of Fluorine in Medicinal Chemistry
Eric P. Gillis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
HIV-1 assembly, release and maturation
Eric O. Freed
NATURE REVIEWS MICROBIOLOGY (2015)
HIV-1 capsid: the multifaceted key player in HIV-1 infection
Edward M. Campbell et al.
NATURE REVIEWS MICROBIOLOGY (2015)
X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability
Anna T. Gres et al.
SCIENCE (2015)
Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assays
Atsushi Iwamura et al.
TOXICOLOGY IN VITRO (2015)
Structure of the immature HIV-1 capsid in intact virus particles at 8.8 Å resolution
Florian K. M. Schur et al.
NATURE (2015)
(DHQ)2AQN-Catalyzed Asymmetric Substitution of Isatin-Derived Hydrazones with O-Boc-Protected Morita-Baylis-Hillman Adducts: A Strategy for Synthesizing Enantioenriched Azo Compounds Incorporating an Oxindole Scaffold
Hai-Bin Yang et al.
JOURNAL OF ORGANIC CHEMISTRY (2014)
Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics
Gongpu Zhao et al.
NATURE (2013)
Structure of the immature retroviral capsid at 8 Å resolution by cryo-electron microscopy
Tanmay A. M. Bharat et al.
NATURE (2012)
High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates
Jens Verheyen et al.
AIDS (2010)
Can the further clinical development of bevirimat be justified?
Mark A. Wainberg et al.
AIDS (2010)
Phenotypic Susceptibility to Bevirimat in Isolates from HIV-1-Infected Patients without Prior Exposure to Bevirimat
Nicolas A. Margot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Predicting Bevirimat resistance of HIV-1 from genotype
Dominik Heider et al.
BMC BIOINFORMATICS (2010)
Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1 maturation inhibitor bevirimat
Catherine S. Adamson et al.
RETROVIROLOGY (2010)
The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation
Mary Ann Checkley et al.
VIROLOGY (2010)
Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1
Kurt Van Baelen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Structure-Activity Relationships for Degradation Reaction of 1-β-O-Acyl Glucuronides: Kinetic Description and Prediction of Intrinsic Electrophilic Reactivity under Physiological Conditions
Akiko Baba et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Structure- Activity Relationships for the Degradation Reaction of 1-beta-O-Acyl Glucuronides. Part 2: Electronic and Steric Descriptors Predicting the Reactivity of 1-beta-O-Acyl Glucuronides Derived from Benzoic Acids
Tadao Yoshioka et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Structure-Activity Relationships for the Degradation Reaction of 1-β-O-Acyl Glucuronides. Part 3: Electronic and Steric Descriptors Predicting the Reactivity of Aralkyl Carboxylic Acid 1-β-O-Acyl Glucuronides
Akiko Baba et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
HIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 Infectivity
Barbara Mueller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
An Oral Human Drug Absorption Study to Assess the Impact of Site of Delivery on the Bioavailability of Bevirimat
Alyson Connor et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
A Strongly Transdominant Mutation in the Human Immunodeficiency Virus Type 1 gag Gene Defines an Achilles Heel in the Virus Life Cycle
Sook-Kyung Lee et al.
JOURNAL OF VIROLOGY (2009)
Structure and assembly of immature HIV
J. A. G. Briggs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phase I and II study of the safety, virologic effect, and pharmacokinetics/pharmacodynamics of single-dose 3-O-(3′,3′-dimethylsuccinyl)betulinic acid (bevirimat) against human immunodeficiency virus infection
Patrick F. Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients
Isabelle Malet et al.
AIDS (2007)
Interactions between HIV-1 Gag molecules in solution: An inositol phosphate-mediated switch
Siddhartha A. K. Datta et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Acyl glucuronides: Biological activity, chemical reactivity, and chemical synthesis
Andrew V. Stachulski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists
R Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Proteases universally recognize beta strands in their active sites
JDA Tyndall et al.
CHEMICAL REVIEWS (2005)
Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation
J Zhou et al.
JOURNAL OF VIROLOGY (2004)
PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing
F Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Palladium-catalyzed cross-coupling reaction of bis(pinacolato)diboron with 1-alkenyl halides or triflates: Convenient synthesis of unsymmetrical 1,3-dienes via the borylation-coupling sequence
J Takagi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Rate acceleration of the Baylis-Hillman reaction in polar solvents (water and formamide). Dominant role of hydrogen bonding, not hydrophobic effects, is implicated
VK Aggarwal et al.
JOURNAL OF ORGANIC CHEMISTRY (2002)
Modulation of HIV-like particle assembly in vitro by inositol phosphates
S Campbell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation
T Kanamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
